{"nct_id":"NCT04183335","title":"Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2019-12-12","start_date_type":"ACTUAL","primary_completion_date":"2021-11-12","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}